Common adverse events associated with an SSRI: Meta-analysis of early paroxetine data

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 7, 2008, Pages 707-713

  Aursnes, Ivar ^a   Gjertsen, Marianne Klemp ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Adverse effects; Paroxetine; SSRI

Indexed keywords

PAROXETINE; PLACEBO;

ABNORMAL SENSATION; AGITATION; ANXIETY; ARTICLE; ASTHENIA; BLURRED VISION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONFUSION; CONSTIPATION; DECREASED APPETITE; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; DYSPEPSIA; EJACULATION DISORDER; HEADACHE; HUMAN; IMPOTENCE; INCREASED APPETITE; INSOMNIA; LIBIDO DISORDER; MAJOR DEPRESSION; MALE GENITAL SYSTEM DISEASE; META ANALYSIS; MICTURITION DISORDER; MYOCLONUS; NAUSEA; NERVOUSNESS; OROPHARYNX; PARESTHESIA; POLLAKISURIA; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; SOMNOLENCE; SWEATING; SYSTEMATIC REVIEW; TASTE DISORDER; TREMOR; VOMITING; XEROSTOMIA; YAWNING;

ADOLESCENT; ADULT; AGED; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; DRUG LABELING; HUMANS; MIDDLE AGED; PAROXETINE; RISK; SEROTONIN UPTAKE INHIBITORS;

EID: 48249103108     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1596     Document Type: Article

References (16)

1. Eudravigilance. http://eudravigilance.emea.europa.eu/human/index.asp [27/ 09/2007].
2. Claghorn JL. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients. J Clin Psychiatry 1992; 53(Suppl.): 21-26.
3. Dunner DL, Dunbar GC. Optimal dose regimen for paroxetine. J Clin Psychiatry 1992; 53(Suppl.): 21-26.
4. Feighner JP, Cohn JB, Fabre LF, Jr., Fieve RR, Mendels J, Shrivastava RK, Dunbar GC. A study comparing placebo and imipramine in depressed patients. J Affect Disord 1993; 28: 71-79.
5. Cohn JB, Crowder JE, Wicox CS, Ryan PJ. A placebo- and imipramine-controlled study of paroxetine. Psychopharmacol Bull 1990; 26: 185-190.
6. Kiev A. A double-blind, placebo-controlled study of paroxetine in depressed outpatients. J Clin Psychiatry 1992; 53(2(Suppl.)): 27-29.
7. Claghorn JI, Feighner JP. A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression. J Clin Psychopharm 1993; 13(Suppl. 2): 23S-28S.
8. US Food and Drug Administration. COSTART. Coding Symbols for Thesaurus of Adverse Reaction Terms. (3rd edn.), Center for Drugs and Biologics, Division of Drug and Biologic Products Experience: Rockville, MD, 1985; Publication no. HFN-735.
9. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Academic Press: San Diego, CA, 1985.
10. European Medicines Agency. Note for Guidance on Statistical Principles for Clinical Trials. CPMP/ICH/363/96, 1998; 1-37. http://www.emea.eu.int/pdfs/human/ich/036396en.pdf [27/09/2007].
11. Sutton AJ, Cooper NJ, Lambert PC, Jones DR, Abrams KR, Sweeting MJ. Meta-analysis of rare and adverse event data. Expert Rev Pharmacoeconomics Outcomes Res 2002; 2: 367-379.
12. Eaton L. "Yellow card" announcement used to head off concerns, experts claim. BMJ 2003; 327: 308.
13. Decullier E, Lhéritier V, Chapuis F. Fate of biomedical research protocols and publication bias in France: retrospective cohort study. BMJ 2006; 351: 19-122.
14. Aursnes I, Tvete IF, Gaasemyr J, Natvig B. Suicide attempts in clinical trials with paroxetine randomised against placebo. BMC Med 2005; 3: 14. DOI:10.1186/1741-7015-3-14
15. Aursnes I, Tvete IF, Gaasemyr J, Natvig B. Even more suicide attempts in clinical trials with paroxetine randomised against placebo. BMC Psychiatry 2006; 6: 55. D0I:10.1186/1471-244X-6-55
16. Healy D, Herxheimer A, Menkes DB. Antidepressants and violence: Problems at the interface of medicine and law. PLoS Med 2006; 3(9): e372. DOI: 10.1371/journal.pmed.0030372